Amgen Inc. Canadian Depositary Receipt (AMG0)
FSX
Real-time Data
06:00 AM
Day's Range
20.0052 wk Range
12.30Overview - AMG0 - Amgen Inc. Canadian Depositary Receipt
Key Statistics
Valuation
Enterprise Value
290.44B
P/E (Trailing)
‪25.92‬
PEG Ratio
‪0.39‬
Price / Sales (TTM)
‪5.09‬
Price / Book
‪29.58‬
EV / EBITDA
‪19.64‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪22.95%‬
Operating Margin
‪35.54%‬
Return on Assets
‪8.66%‬
Return on Equity
‪91.47%‬
Ownership
Shares Outstanding
541.00M
Float
14.97B
Price stats
Beta
‪0.41‬
50-Day Avg
‪17.23‬
200-Day Avg
‪16.29‬
Dividends
Payout Ratio
‪59.97%‬
Frequency
Quarterly
Market Cap - AMG0 - Amgen Inc. Canadian Depositary Receipt
Peers - AMG0 - Amgen Inc. Canadian Depositary Receipt
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
- AMG0FSXAmgen Inc. Canadian Depositary Receipt194.06BMarket Cap+30.96%52-week change25.92P/E (Trailing)‪22.95%‬Profit Margin
- LLYFSXEli Lilly and Company967.12BMarket Cap+44.42%52-week change42.55P/E (Trailing)‪33.52%‬Profit Margin
- LLY0FSXEli Lilly CDR888.80BMarket Cap+39.18%52-week change38.26P/E (Trailing)‪33.52%‬Profit Margin
- JNJFSXJohnson & Johnson566.92BMarket Cap+35.24%52-week change31.88P/E (Trailing)‪21.48%‬Profit Margin
- JNJ0FSXJohnson & Johnson CDR520.56BMarket Cap+33.96%52-week change29.17P/E (Trailing)‪21.48%‬Profit Margin
- 4ABFSXAbbVie Inc.402.01BMarket Cap+22.14%52-week change75.13P/E (Trailing)‪9.80%‬Profit Margin
- 4AB0FSXAbbVie Inc. CDR364.00BMarket Cap+19.44%52-week change75.63P/E (Trailing)‪9.80%‬Profit Margin
Profile Summary - AMG0 - Amgen Inc. Canadian Depositary Receipt
About
Amgen Inc. Canadian Depositary Receipt (CDR) is a financial instrument that provides Canadian investors with exposure to Amgen Inc., a leading biotechnology company focused on developing innovative human therapeutics. This CAD-hedged CDR represents fractional ownership of Amgen Inc. common stock through a dynamic CDR…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
